|Bid||0.0400 x 0|
|Ask||0.0700 x 0|
|Day's Range||0.0650 - 0.0650|
|52 Week Range||0.0200 - 0.5000|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
HOUSTON, TX / ACCESSWIRE / December 4, 2018 / Controversial or not, it's tough to overlook the growth of the cannabis industry. Canada just recently legalized its use throughout the country. Three more U.S. states just approved its recreational and, or medicinal use.
Vancouver, British Columbia and Medellin, Colombia--(Newsfile Corp. - November 29, 2018) - Orion Nutraceuticals Inc., (CSE: ORI) (the "Company" or "Orion") a cannabis life science company, is pleased to announce continued milestone advancement by its Colombian-based strategic ally and supply partner, FCM Global S.A.S. ("FCM"). Orion benefits from FCM's ability to supply low-cost, high-quality extracts, enabling Orion to win sizable long-term purchase orders for their finished products from top-tier international clients, including ...
Investorideas.com, a leading investor news resource for cannabis stocks releases a snapshot looking at CBD and its future role as a pain treatment in healthcare, and how it is being advocated and embraced by professional athletes. The World Anti-Doping Agency (WADA) officially removed cannabidiol (CBD) from its Prohibited Substances List effective January 1, 2018 and that has opened up a lot of opportunity for athletes looking for more natural pain treatment solutions and companies in the space. In June of this year, The BIG3 basketball league announced they will allow players to use cannabidiol (CBD) as a pain treatment and for recovery.
Vancouver, BC, Nov. 20, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Orion Nutraceuticals Inc., (CSE: ORI) (the “Company” or “Orion”) a cannabis life science company, is pleased to announce the addition of Shannon Ford-Smith, sports healthcare and CBD product expert to its advisory board. Shannon Ford-Smith has a uniquely diverse background that includes education, construction, consumer goods as well as experience building and leading companies in the sports healthcare sector.
Vancouver, British Columbia--(Newsfile Corp. - November 15, 2018) - Orion Nutraceuticals Inc. (CSE: ORI) (the "Company" or "Orion") a cannabis life science company, is pleased to announce the addition of Matthew Bennett, President and Founder of Bennett's Choice, to its advisory board.Matthew Bennett is a leader in improving recovery from concussions and preventing neurological disease. He has successfully pitched on Dragons' Den and partnered with world renowned coaches to promote the importance of nourishing the ...
Vancouver, BC, Nov. 15, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Orion Nutraceuticals Inc., (CSE: ORI) (the “Company” or “Orion”) a cannabis life science company, is pleased to announce the addition of Matthew Bennett, President and Founder of Bennett’s Choice, to its advisory board. Matthew Bennett is a leader in improving recovery from concussions and preventing neurological disease. Matthew will share his natural medicine-based experience to boost Orion contracts with professional athletes, teams and academies by promotion of the positive effects of Orion products. Matthew will work to establish easy and accessible ways to help the athletes sleep and recovery which empowers their performance and life for optimal active pain-free living.